At a glance
ClinicalIndex Comparison RecordN/ACompleted· 288 enrolled
Drug / intervention
silver SPC +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Control Trial of Silver-alloy Impregnated Suprapubic Catheters in Urogynecology Patients
In Brief
A clinical study evaluating silver SPC and standard SPC for Infection Associated With Catheter and Urinary Tract Infection. Completed, enrolled 288 participants across 1 site.
Detailed Summary
The purpose of this study is to compare urinary tract infection rates among women undergoing urogynecological procedures with a silver-alloy suprapubic catheter compared to the standard suprapubic catheter.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMay 2011
Enrollment StartJul 2011
Primary CompletionMar 2018
Study CompletionMar 2018
TodayJul 2026
First PostedMay 24, 2011
Enrollment StartJul 1, 2011
Primary CompletionMar 2, 2018
Study CompletionMar 9, 2018
TodayJul 2, 2026
Enrollment to primary: 6.7 yearsPosted 15.1 years ago
Interventions
silver SPCdevice
subject randomized to receive silver alloy impregnated catheter
standard SPCdevice
subject randomized to receive standard catheter